Reviving the Extinct: Colossal Biosciences’ Ambitious Quest to Resurrect Lost Species

Rebecca Stone, Science Editor
5 Min Read
⏱️ 4 min read

In a Dallas business park, the future of extinct species is being actively shaped by Colossal Biosciences, a company at the forefront of de-extinction technology. With a staggering valuation of $10.2 billion, Colossal has garnered both accolades and scepticism following its announcement of successfully breeding dire wolf pups—an achievement that has reignited the debate over the ethics and practicality of resurrecting long-gone species.

The Quest for De-extinction

Colossal Biosciences, buoyed by substantial financial backing from a diverse group of investors including celebrities like Tiger Woods and Paris Hilton, aims to reverse extinction through advanced genetic editing techniques. Following the birth of three dire wolf pups—dubbed Romulus, Remus, and Khaleesi—the company has set its sights on reviving the woolly mammoth and, eventually, the infamous dodo.

Ben Lamm, the CEO of Colossal, emphasises a “moral obligation” to combat the ongoing extinction crisis, which is reportedly taking place at a rate up to 1,000 times higher than natural causes. “We need to engage the public, especially parents in middle America, about conservation and the wonders of science,” Lamm noted, underlining the company’s mission to stimulate interest in biodiversity.

The Science Behind the Spectacle

At the heart of Colossal’s operations is a cutting-edge laboratory spanning 55,000 square feet, where teams of scientists are diligently working to isolate ancient DNA and employ CRISPR technology for gene editing. The process involves intricate modifications to the genomes of existing species that are closely related to those being revived. For instance, in the case of the dire wolf, 14 out of 19,000 genes from the grey wolf were altered to create a hybrid that is larger, cold-resistant, and snow-coloured.

The Science Behind the Spectacle

However, the path to de-extinction is fraught with challenges. Unlike mammals, birds such as the dodo present unique difficulties since they cannot be cloned from skin or hair samples. Colossal is currently cultivating primordial germ cells from pigeons, the dodo’s nearest living relative, while also exploring options for the moa, a colossal flightless bird that once roamed New Zealand.

Controversy and Criticism

Despite the ambitious nature of its projects, Colossal faces significant criticism from segments of the scientific community. Critics argue that the company’s efforts may be more about public relations than genuine scientific advancement. Vincent Lynch, an evolutionary developmental biologist, contends that creating a genetically modified grey wolf does not equate to resurrecting a true dire wolf: “You can’t simply edit genes and claim to have brought back a species,” he stated, highlighting philosophical and biological complexities surrounding species definitions.

Others express concern that the excitement generated by de-extinction initiatives could detract from ongoing conservation efforts. Critics warn that a “Lazarus effect” might lead to complacency regarding the protection of endangered species, as the belief that we can simply resurrect them in the future may reduce the urgency of current conservation measures.

The Future of Conservation

While the spotlight may currently shine on spectacular de-extinction efforts, the true impact of Colossal’s technology could extend far beyond the resurrection of iconic species. The company is also developing methods to enhance genetic diversity among endangered species such as the red wolf and aims to create vaccines against diseases threatening the Asian elephant population.

The Future of Conservation

Lamm asserts that Colossal’s broader mission is one of species preservation, stating, “We interpret ‘de-extinction’ as a pathway to develop next-generation conservation tools.” This perspective aligns with the notion that while reviving extinct species is a captivating concept, the pressing need remains to safeguard and sustain existing biodiversity before it is lost forever.

Why it Matters

As humanity grapples with a rapid loss of biodiversity, Colossal Biosciences stands at the intersection of science and ethical inquiry. The implications of their work could reshape conservation strategies and provoke discussions on the moral responsibilities we bear toward our planet and its myriad inhabitants. While the allure of resurrecting the past captures the imagination, it is critical to focus on contemporary conservation challenges that demand immediate attention. The future of our ecosystems may depend not only on the revival of lost species but also on the commitment to protect those that remain.

Share This Article
Rebecca Stone is a science editor with a background in molecular biology and a passion for science communication. After completing a PhD at Imperial College London, she pivoted to journalism and has spent 11 years making complex scientific research accessible to general audiences. She covers everything from space exploration to medical breakthroughs and climate science.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2026 The Update Desk. All rights reserved.
Terms of Service Privacy Policy